Murphy John Raymond's Form 4 filing
Cadrenal Therapeutics, Inc. (CVKD) · filed Oct 6, 2023
- Accession no.
- 0001213900-23-081216
- Filed
- Oct 6, 2023
- Trade date
- Oct 4-5, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $14.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Murphy John RaymondCIK 0001275195 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2023 | Common Stock | PPurchaseAcquired | +17,331 | $0.70 | +$12,131.7 | 612,123 | Direct | |
| Oct 5, 2023 | Common Stock | PPurchaseAcquired | +2,669 | $0.69 | +$1,841.61 | 614,792 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.